Financing ·
Endovia Health Sciences amends equity line of credit to increase total commitment from $35M to $135M
EDVAEndovia Health Sciences, Inc.
On October 22, 2026, Endovia Health Sciences entered into an addendum to its Securities Purchase Agreement with C/M Capital Master Fund, LP. The amendment increases the maximum commitment amount under the equity line of credit facility from $35 million to $135 million, inclusive of prior sales. Updated terms apply to future share issuances exceeding the initial 10,875,000 shares already sold under the original agreement filed in September 2025. Endovia Health Sciences operates in the healthcare sector.